Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
39.83
+0.86 (2.21%)
At close: Apr 29, 2024, 4:00 PM
40.00
+0.17 (0.43%)
After-hours: Apr 29, 2024, 7:55 PM EDT
BHVN Employees
Biohaven Pharmaceutical Holding Company had 239 employees on December 31, 2023. The number of employees increased by 37 or 18.32% compared to the previous year.
Employees
239
Change (1Y)
37
Growth (1Y)
18.32%
Revenue / Employee
n/a
Profits / Employee
-$1,707,816
Market Cap
3.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 239 | 37 | 18.32% |
Dec 31, 2022 | 202 | 12 | 6.32% |
Dec 31, 2021 | 190 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Fortrea Holdings | 19,000 |
Surgery Partners | 13,500 |
Evolent Health | 4,700 |
Sotera Health Company | 3,000 |
HUTCHMED (China) | 1,988 |
Progyny | 566 |
Iovance Biotherapeutics | 557 |
BHVN News
- 7 days ago - Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 12 days ago - Biohaven Announces Pricing of $230 Million Public Offering of Common Shares - PRNewsWire
- 12 days ago - Biohaven Announces Proposed Public Offering of Common Shares - PRNewsWire
- 16 days ago - Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates - PRNewsWire
- 2 months ago - Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments - PRNewsWire
- 4 months ago - Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology - PRNewsWire
- 4 months ago - Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 5 months ago - Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting - PRNewsWire